Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A targeted DNA vaccine encoding Fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis
Gizi Wildbaum, … , Gila Maor, Nathan Karin
Gizi Wildbaum, … , Gila Maor, Nathan Karin
Published September 1, 2000
Citation Information: J Clin Invest. 2000;106(5):671-679. https://doi.org/10.1172/JCI8759.
View: Text | PDF
Article Article has an altmetric score of 6

A targeted DNA vaccine encoding Fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis

  • Text
  • PDF
Abstract

This study used naked DNA vaccination to induce breakdown of tolerance to self and thus elicit immunological memory to native, membrane-bound Fas ligand (FasL). Upon induction of experimental autoimmune encephalomyelitis (EAE), this memory was turned on to provide protective immunity. FasL-specific autoantibodies isolated from protected animals differentially downregulated the in vitro production of TNF-α, but not IFN-γ, by cultured T cells. These autoantibodies were highly protective when they were administered to rats at the onset of EAE. In contrast, administration of these FasL-specific Ab’s to EAE rats after the peak of the acute phase of disease prevented spontaneous recovery from disease. This extended illness is partially explained by inhibition of mononuclear cell apoptosis at the target organ, which resulted in increased accumulation of T cells and macrophages at the site of inflammation. Hence, FasL exerts two distinct, stage-specific regulatory functions in the control of this T-cell mediated autoimmune disease of the central nervous system.

Authors

Gizi Wildbaum, Juergen Westermann, Gila Maor, Nathan Karin

×

Total citations by year

Year: 2020 2018 2012 2010 2008 2005 2003 2002 Total
Citations: 1 1 1 1 1 1 2 1 9
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (9)

Title and authors Publication Year
CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond
N Karin
Frontiers in immunology 2020
Autoantibodies to Chemokines and Cytokines Participate in the Regulation of Cancer and Autoimmunity
N Karin
Frontiers in immunology 2018
Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases
L Tian, L Ma, T Kaarela, Z Li
Journal of Neuroinflammation 2012
Antigen-Specific CD25−Foxp3−IFN-γhighCD4+ T Cells Restrain the Development of Experimental Allergic Encephalomyelitis by Suppressing Th17
G Wildbaum, Y Zohar, N Karin
The American Journal of Pathology 2010
Vaccines for Multiple Sclerosis: Progress to Date
J Correale, M Farez, W Gilmore
CNS Drugs 2008
Failed Central Nervous System Regeneration: A Downside of Immune Privilege?
I Bechmann
NeuroMolecular Medicine 2005
Fas Ligand-Mediated Apoptosis in Degenerative Disorders of the Brain
DW Ethell, LA Buhler
Journal of Clinical Immunology 2003
Fas ligand-mediated apoptosis in degenerative disorders of the brain
Douglas W Ethell, Lillian A Buhler
Journal of Clinical Immunology 2003
Soluble peptide therapy with a heterologous determinant elicits an Ag specific regulatory mechanism that prevents pathological consequences during epitope spreading
Gizi Wildbaum, Nir Netzer, Nathan Karin
Journal of Clinical Investigation 2002

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 5 patents
9 readers on Mendeley
See more details